147 related articles for article (PubMed ID: 12563981)
1. [The meaning of the expression of PCNA and c-erbB-2 in the hyperplasia of laryngeal epithelium].
Yao Q; Lu X; Huang Z; Cao Y; Jiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):263-4. PubMed ID: 12563981
[TBL] [Abstract][Full Text] [Related]
2. [Expression of proliferating cell nuclear antigen (PCNA) in premalignant lesions of laryngeal epithelium].
Zhou G; Lin D; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):206-8. PubMed ID: 8745457
[TBL] [Abstract][Full Text] [Related]
3. [An immunohistochemical study of proliferating cell nuclear antigen (PCNA) and MIB-1 in epithelial hyperplasia and dysplasia of the vocal cords].
Urano M; Iwata S; Takasu A; Mori S; Sakurai K; Katoh H; Yamamoto S; Kasahara M; Kuroda M; Hakuno T
Nihon Jibiinkoka Gakkai Kaiho; 1996 Mar; 99(3):395-401. PubMed ID: 8934774
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szkudlarek T; Jeleń-Krzeszewska J
Oral Oncol; 1999 Mar; 35(2):180-6. PubMed ID: 10435153
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
6. Immunohistological comparison of the World Health Organization (WHO) and Ljubljana classifications on the grading of preneoplastic lesions of the larynx.
Sengiz S; Pabuççuoğlu U; Sarioğlu S
Pathol Res Pract; 2004; 200(3):181-8. PubMed ID: 15200269
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between tumor cell proliferating activity and biological behavior, prognosis in laryngeal carcinoma].
Zhou G; Liang C; Lin D; Zhang X; Wen D; Liu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):178-81. PubMed ID: 10684010
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinoma - an aid to conventional histological grading?
Zain RB; Sakamoto F; Shrestha P; Mori M
Malays J Pathol; 1995 Jun; 17(1):23-30. PubMed ID: 8907001
[TBL] [Abstract][Full Text] [Related]
10. Quantitative pathology of laryngeal epithelial hyperplastic lesions.
Cör A; Gale N; Kambic V
Acta Otolaryngol Suppl; 1997; 527():57-61. PubMed ID: 9197483
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of retinoic acid receptor beta (RARbeta) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues.
Karamouzis MV; Sotiropoulou-Bonikou G; Vandoros G; Varakis I; Papavassiliou AG
Eur J Cancer; 2004 Mar; 40(5):761-73. PubMed ID: 15010078
[TBL] [Abstract][Full Text] [Related]
12. Retinoid X receptor overexpression desensitizes laryngeal epithelium to carcinogenic effects associated with epidermal growth factor receptor upregulation.
Kourelis K; Vandoros G; Kourelis T; Goumas P; Sotiropoulou-Bonikou G
J Otolaryngol Head Neck Surg; 2009 Apr; 38(2):233-9. PubMed ID: 19442374
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
[TBL] [Abstract][Full Text] [Related]
14. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
Zidar N; Gale N; Cör A; Kambic V
J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
[TBL] [Abstract][Full Text] [Related]
15. Value of exfoliative cytology in differential diagnosis of epithelial hyperplastic lesions of the larynx.
Beham A; Regauer S; Friedrich G; Beham-Schmid C
Acta Otolaryngol Suppl; 1997; 527():92-4. PubMed ID: 9197491
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx.
Gale N; Zidar N; Kambic V; Poljak M; Cör A
Acta Otolaryngol Suppl; 1997; 527():105-10. PubMed ID: 9197495
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions.
Chatrath P; Scott IS; Morris LS; Davies RJ; Rushbrook SM; Bird K; Vowler SL; Grant JW; Saeed IT; Howard D; Laskey RA; Coleman N
Br J Cancer; 2003 Sep; 89(6):1048-54. PubMed ID: 12966424
[TBL] [Abstract][Full Text] [Related]
18. Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx.
Zhao R; Hirano M; Kurita S
Am J Otolaryngol; 1996; 17(1):36-44. PubMed ID: 8801814
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
20. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.
Gallo O; Franchi A; Chiarelli I; Porfirio B; Grande A; Simonetti L; Bocciolini C; Fini-Storchi O
Acta Otolaryngol Suppl; 1997; 527():30-8. PubMed ID: 9197477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
